sj-docx-1-mso-10.1177_20552173231201422 - Supplemental material for Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies

Supplemental material, sj-docx-1-mso-10.1177_20552173231201422 for Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies by Antoine Regnault, Angely Loubert, Róisín Brennan, Juliette Meunier, Christel Naujoks, Stefan Cano and Nicholas Adlard in Multiple Sclerosis Journal – Experimental, Translational and Clinical</p